Choksi Laborator

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE493D01013
  • NSEID:
  • BSEID: 526546
INR
121.00
0.00 (0.00%)
BSENSE

Feb 01

BSE+NSE Vol: 30.54 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Aspira Pathlab
Shree Pacetronix
Jeevan Scienti.
Choksi Laborator
Bilcare
Star Imaging
Modern Diagnost.
Royal Sense
Amkay Products
Invicta Diagnos.
Aakaar Medical

Why is Choksi Laboratories Ltd ?

1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 7.91%
  • Poor long term growth as Net Sales has grown by an annual rate of 11.69% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.61 times
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Choksi Laborator for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Choksi Laborator
-12.06%
-0.06
54.64%
Sensex
4.64%
0.46
11.21%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.69%
EBIT Growth (5y)
37.65%
EBIT to Interest (avg)
1.36
Debt to EBITDA (avg)
4.91
Net Debt to Equity (avg)
1.17
Sales to Capital Employed (avg)
0.64
Tax Ratio
37.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
5.69%
ROCE (avg)
5.71%
ROE (avg)
6.51%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
51
Industry P/E
81
Price to Book Value
3.44
EV to EBIT
22.04
EV to EBITDA
9.51
EV to Capital Employed
2.13
EV to Sales
2.56
PEG Ratio
1.50
Dividend Yield
NA
ROCE (Latest)
9.65%
ROE (Latest)
6.78%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
OPERATING CF(Y)

Highest at Rs 11.78 Cr

ROCE(HY)

Highest at 9.72%

PAT(9M)

Higher at Rs 1.55 Cr

NET SALES(Q)

At Rs 11.12 cr has Grown at 20.09%

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Choksi Laborator

Operating Cash Flow - Annually
Highest at Rs 11.78 Cr and Grown
each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Net Sales - Quarterly
At Rs 11.12 cr has Grown at 20.09%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Nine Monthly
Higher at Rs 1.55 Cr
than preceding 12 month period ended Sep 2025 of Rs 1.29 cr
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)